Release date: 2016-01-05
In the eyes of scientists, entrepreneurs, and medical investors, what new medical technologies deserve our continued attention in 2016? The "First Financial Daily" reporters interviewed and sorted out the medical hotspots that may still be concerned by capital and policy in 2016.
NO.1 Diagnostic industry
With the entry of clinical medicine into the era of precision medicine, the diagnosis will not only be limited to the diagnosis of diseases, but also cover all aspects of clinical treatment such as disease prevention, diagnosis, treatment plan formulation, and treatment effect evaluation. In 2015, a group of leading IVD (Molecular Diagnostics) companies in China successfully achieved IPOs. The traditional pharmaceutical industry and transformed listed companies are also testing the IVD industry. Under the focus of various capitals, we believe that the capital integration of the IVD industry is the trend of the times. On the one hand, the integration and integration of innovative technologies, and on the other hand, the integration and integration of IVD channels and service provider providers, the upstream and downstream chains of the industry will gradually open up.
NO.2 artificial organs
Along with artificial organs, 3D printing technology and wearable devices are being developed. A recent Frost & Sullivan study on consumer behavior and digital healthcare shows that the proportion of consumers using wearable devices may rise to 47% in the near future. While 3D printing is applied to artificial organs, 3D printing organs that can be fused to the human body can be applied to clinical fields, such as internal organs and limbs. In China, once the clinical market access is released, it is accompanied by more With the continuous development of biomaterials, the application of 3D printing in medicine in 2016 is also expected to usher in an explosion.
NO.3 Precision Medicine
Since the beginning of 2015, after President Obama announced the precision medical plan, the heat of precision treatment in the capital and industry has been completely ignited. Many of the original treatment methods are generalized and treated according to statistical laws, but now the personalized means represented by cancer cell therapy will benefit the patient's later effects in the future, and related targeted drugs. Stem cell therapy, genetic diagnosis, etc. will continue to be the focus of attention in the market.
N0.4 Internet Medical
At the World Internet Conference held in Wuzhen in 2015, the first “electronic prescription†flowed out. Although this is not a true electronic prescription in the strict sense, the Internet + medical care has actually developed to the crossroads of the outbreak. In 2014, the National Health and Family Planning Commission had solicited opinions on the release of prescription drugs on the Internet. However, after a year and a half, the online sales of prescription drugs have not been effectively promoted, and it is quite “shelvedâ€, but actually in 2015. In the year, including pharmaceutical companies, pharmaceutical distributors, and retailers, the focus has been on this. The main profit is currently in medical devices, health care products, and OTC drugs. If the prescription drug that accounts for 80% of the drug consumption share in 2016 is released, the industry expects The market will grow three times more space.
No.5 Regenerative medicine
It is predicted that the recycling market business will increase by 22.4% compared with 2015, which will become the new trump card of many drug manufacturers. With the expansion of investment in this field, the enactment of favorable legislative policies and the increasing launch of cell therapy products, a large number of new competitors will emerge in order to gain a foothold in this field.
No.6 gene editing
Is it an angel or a devil? For genetic editing, there has been constant controversy at the ethical and scientific levels, and the technologies involved may cure a variety of major diseases, including depression and AIDS, which were previously incurable by drug treatment alone. But it also raises concerns that it will bring an unprecedented disaster to mankind: for example, it can give humans a custom fetus. At the beginning of December 2015, the world's top scholars in the field of genetic research gathered in Washington for a three-day international summit on human genetic editing. At the conference, scholars explored the scientific, ethical and regulatory issues brought about by the revolutionary technology of "gene editing". To be sure, in 2016, genetic editing will still be a hot topic in medical discussion.
N0.7 cerebrovascular stent thrombectomy
Stroke, as one of the three major killers of human health, has the characteristics of high incidence, high disability rate and high mortality. Once a thrombus occurs in the brain, it must be removed within 3 to 6 hours. Otherwise, it is mildly disabled and the severe one is directly killed. In the past, not only were there fewer types of drugs for treating this disease, but the success rate was not high. However, the birth of cerebral vascular stent thrombectomy will completely change the treatment rules of ischemic stroke. This device is called a mechanical extractor and a metal cage. Unlike traditional medical treatment, cerebral vascular stent thrombectomy is the direct removal of the thrombus. The first-generation thrombectomy device was approved by the FDA in 2012; the second-generation thrombectomy device is considered to be essential for all thrombosis patients, and the industry expects to meet the public at the end of 2016.
No.8 Private medical care
At the policy level, social capital entering the medical system is gradually being liberalized. In 2014, whether it was the investment in private hospitals, the listing of private hospitals represented by Corning, or the outbreak of private maternity hospitals, social capital entering the traditional medical system is trying to find the most suitable way. With the further promotion of policies such as multi-point medical treatment and public hospital reform in 2015, private medical care will continue to be a hot topic of medical investment.
Source: First Financial Daily
Metallurgical Microscope ,Optical Metallurgical Microscope,Portable Metallurgical Microscope,Inverted Metallographic Microscope
Ningbo ProWay Optics & Electronics Co., Ltd. , https://www.proway-microtech.com